The OS and RS of GIST with the exon 18 PDGFR gene mutation could indicate that this subgroup of patients may be less aggressive and have a good prognosis, although less sensitive to treatment at recurrence. The gene discussed is PDGFRB; the disease is gastrointestinal stromal tumor.